Relx (NYSE:RELX) Sets New 52-Week High – Still a Buy?

Relx Plc (NYSE:RELX)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $50.56 and last traded at $50.56, with a volume of 130415 shares changing hands. The stock had previously closed at $49.86.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. StockNews.com initiated coverage on shares of Relx in a research report on Wednesday, October 30th. They issued a “hold” rating for the company. Redburn Atlantic began coverage on shares of Relx in a report on Wednesday, January 8th. They issued a “buy” rating for the company.

Relx Stock Performance

The company has a quick ratio of 0.42, a current ratio of 0.48 and a debt-to-equity ratio of 1.63. The firm has a market cap of $93.04 billion, a P/E ratio of 27.17, a P/E/G ratio of 3.26 and a beta of 0.90. The business has a fifty day simple moving average of $47.39 and a 200-day simple moving average of $46.94.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RELX. JPMorgan Chase & Co. increased its holdings in shares of Relx by 14.6% during the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock valued at $39,225,000 after acquiring an additional 104,999 shares in the last quarter. CWA Asset Management Group LLC bought a new stake in Relx during the 3rd quarter valued at about $548,000. Merit Financial Group LLC purchased a new position in Relx in the fourth quarter worth about $301,000. International Assets Investment Management LLC bought a new position in shares of Relx in the third quarter worth approximately $1,268,000. Finally, Franklin Resources Inc. grew its holdings in shares of Relx by 3.3% during the third quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company’s stock valued at $873,000 after buying an additional 588 shares during the last quarter. Institutional investors own 15.02% of the company’s stock.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.